Chicago Prostate Cancer Center offers free prostate cancer guide

NewsGuard 100/100 Score

Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society.

In its continuing efforts to share information about this prevalent disease, the world-renowned Chicago Prostate Cancer Center has developed a complimentary 22-page guide and DVD to anyone interested in learning more about prostate cancer.

The full-color, spiral-bound guide includes:

  • Detailed discussions about early detection and its importance, including information on the breakthrough diagnostic tool-the Stereotactic Transperineal Prostate Biopsy (STPB)
  • Details of the Gleason Scoring Grade
  • Full explanation of the prostate specific antigen (PSA) blood test
  • Comprehensive discussion of risk factors
  • Myths regarding treatment
  • Frequently Asked Questions about prostate cancer and screening
  • Complete list of questions for patients to ask their doctor
  • Easy-to-understand color graphics
  • Statistics and research on the three forms of treatment including external beam radiation, surgery and brachytherapy

The DVD touches on the above information in addition to detailing the experiences of several prostate cancer survivors.

The latest 2009 American Cancer Society estimates for prostate cancer in the United States predict that an estimated 193,000 new cases of prostate cancer will be diagnosed and 27,360 men will die of prostate cancer. The more information the public has about this disease and about the importance of early screening, the greater the odds of saving a father, brother or grandfather's life.

To obtain the free, color resource book "Prostate Cancer: A Guide to Treatment and Support," call 630-654-2515 or visit www.prostateimplant.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer